BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions, with no guaranteed timing, size, or terms.
Proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Proposed Public Offering
BioSig Technologies, Inc. plans to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds will be used to purchase gold bullion according to the investment policy and for general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers for the offering.
Registration Statement
The offering is being made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC on Dec. 17, 2024.
- BioSig Technologies aims to raise capital through the public offering to support its investment policy and corporate operations.
- The involvement of book-running managers indicates a structured approach to the offering process.
The proposed public offering by BioSig Technologies Inc. demonstrates its strategic approach to raising capital and supporting its investment policy and business operations. The collaboration with book-running managers adds credibility to the offering process.